Raleigh Capital Management Inc. Dexcom Inc Transaction History
Raleigh Capital Management Inc.
- $232 Million
- Q2 2024
A detailed history of Raleigh Capital Management Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 152 shares of DXCM stock, worth $10,495. This represents 0.01% of its overall portfolio holdings.
Number of Shares
152
Previous 151
0.66%
Holding current value
$10,495
Previous $20,000
15.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.21 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.38 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.13 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.06 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$825 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...